Associated Papers
Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity.
Segura-Tudela A et al.
Journal of Clinical Immunology, 2024
38363452 (PubMed )
Supplement: 10875_2024_1664_MOESM1_ESM.docx
Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.
Mondal T et al.
Cell Death and Differentiation, 2023
The genetic landscape of the FAS pathway deficiencies.
Magerus A et al.
Biomedical Journal, 2021
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
Casamayor-Polo L et al.
Critical Reviews in Clinical Laboratory Sciences, 2021
Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Magerus-Chatinet A et al.
The Journal of Allergy and Clinical Immunology, 2013
Analysis of the CD95 ligand gene in 20 children with autoimmune lymphoproliferative syndrome (ALPS).
Pauly E et al.
Blood, 2006
A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Del-Rey M et al.
Blood, 2006
Select a paper to view details